for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Ascendis Pharma Continues To Monitor And Adapt To Impact Of COVID-19

April 1 (Reuters) - Ascendis Pharma A/S:

* ASCENDIS PHARMA A/S REPORTS FULL-YEAR 2019 FINANCIAL RESULTS

* ASCENDIS PHARMA A/S - CORPORATE MILESTONES REMAIN ON TRACK FOR 2020 DESPITE CURRENT GLOBAL PANDEMIC

* ASCENDIS PHARMA A/S - CONTINUES TO MONITOR AND ADAPT TO IMPACT OF COVID-19

* ASCENDIS PHARMA A/S - ENDED 2019 WITH CASH AND CASH EQUIVALENTS OF EUR 598.1 MILLION. Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up